Biocryst Pharmaceuticals buy Bank of America Co.
Start price
01.07.25
/
50%
€7.65
Target price
01.07.26
€12.73
Performance (%)
-1.44%
Price
04.07.25
€7.54
Summary
This prediction is currently active. With a performance of -1.44%, the BUY prediction for Biocryst Pharmaceuticals by Bank_of_America_Co_ is down slightly. This prediction currently runs until 01.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biocryst Pharmaceuticals | -1.44% |
| iShares Core DAX® | -1.315% |
| iShares Nasdaq 100 | 0.272% |
| iShares Nikkei 225® | -2.496% |
| iShares S&P 500 | 0.504% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Bank of America Corporation from $13.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for BCRX provided by MarketBeat